CNA Exclusive with StanChart CEO - Testing image upload on video

SMRT Trains' full-year net profit is 82.4% less than the previous FY. It made $7.5 million in the financial year ending April 2024. The drop is mainly due to a one-time $40.8 million dividend from its Thomson-East Coast Line. Higher electricity and staff costs also weighed down profits. The gradual recovery in train ridership, as well as higher average fares and savings from continuous internal improvements helped prop up profits. SMRT will invest at least $10 million in the coming year to prioritise growth areas like artificial intelligence and data mining. Nadirah Zaidi reports.

Singaporeans who wish to take part in clinical trials can now better find out how to do so through a new portal. They can also identify which ones are best suited for them. The portal was launched by the Singapore Clinical Research Institute, amid the growing need for new and innovative healthcare studies. CNA spoke to Associate Professor Danny Soon, executive director at the Singapore Clinical Research Institute, and Ms Nidhi Swarup, a patient advocate who supports clinical trials.